Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 2;14(11):751.
doi: 10.3390/toxins14110751.

Neurophysiological Basis of Deep Brain Stimulation and Botulinum Neurotoxin Injection for Treating Oromandibular Dystonia

Affiliations
Review

Neurophysiological Basis of Deep Brain Stimulation and Botulinum Neurotoxin Injection for Treating Oromandibular Dystonia

Hitoshi Maezawa et al. Toxins (Basel). .

Abstract

Oromandibular dystonia (OMD) induces severe motor impairments, such as masticatory disturbances, dysphagia, and dysarthria, resulting in a serious decline in quality of life. Non-invasive brain-imaging techniques such as electroencephalography (EEG) and magnetoencephalography (MEG) are powerful approaches that can elucidate human cortical activity with high temporal resolution. Previous studies with EEG and MEG have revealed that movements in the stomatognathic system are regulated by the bilateral central cortex. Recently, in addition to the standard therapy of botulinum neurotoxin (BoNT) injection into the affected muscles, bilateral deep brain stimulation (DBS) has been applied for the treatment of OMD. However, some patients' OMD symptoms do not improve sufficiently after DBS, and they require additional BoNT therapy. In this review, we provide an overview of the unique central spatiotemporal processing mechanisms in these regions in the bilateral cortex using EEG and MEG, as they relate to the sensorimotor functions of the stomatognathic system. Increased knowledge regarding the neurophysiological underpinnings of the stomatognathic system will improve our understanding of OMD and other movement disorders, as well as aid the development of potential novel approaches such as combination treatment with BoNT injection and DBS or non-invasive cortical current stimulation therapies.

Keywords: botulinum neurotoxin; deep brain stimulation; electroencephalography; globus pallidus; magnetoencephalography; motor function; oromandibular dystonia; sensorimotor function; stomatognathic function.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Corticospinal tract and corticobulbar tract. M1: primary motor cortex, Rt: right, Lt: left.
Figure 2
Figure 2
Bilateral functional connections between the cortex and tongue identified using cortico-muscular coherence analysis. The figure shows contralateral (left hemispheric) dominance of the functional connection between the cortex and right side of the tongue.

Similar articles

Cited by

References

    1. Comella C.L. Systematic review of botulinum toxin treatment for oromandibular dystonia. Toxicon. 2018;147:96–99. doi: 10.1016/j.toxicon.2018.02.006. - DOI - PubMed
    1. Scorr L.M., Factor S.A., Parra S.P., Kaye R., Paniello R.C., Norris S.A., Perlmutter J.S., Bäumer T., Usnich T., Berman B.D., et al. Oromandibular dystonia: A clinical examination of 2020 cases. Front. Neurol. 2021;12:700714. doi: 10.3389/fneur.2021.700714. - DOI - PMC - PubMed
    1. Yoshida K. Botulinum toxin therapy for oromandibular dystonia and other movement disorders in the stomatognathic system. Toxins. 2022;14:282. doi: 10.3390/toxins14040282. - DOI - PMC - PubMed
    1. Albanese A., Bhatia K., Bressman S.B., Delong M.R., Fahn S., Fung V.S., Hallett M., Jankovic J., Jinnah H.A., Klein C., et al. Phenomenology and classification of dystonia: A consensus update. Mov. Disord. 2013;28:863–873. doi: 10.1002/mds.25475. - DOI - PMC - PubMed
    1. Colosimo C., Berardelli A. Clinical phenomenology of dystonia. Int. Rev. Neurobiol. 2011;98:509–524. doi: 10.1016/B978-0-12-381328-2.00018-3. - DOI - PubMed

Publication types

Substances